Written answers
Thursday, 2 July 2015
Department of Defence
Defence Forces Medicinal Products
Clare Daly (Dublin North, United Left)
Link to this: Individually | In context | Oireachtas source
117. To ask the Minister for Defence the number of soldiers who were administered mefloquine and Primaquine by the Army, despite having been diagnosed as glucose-6-phosphate dehydrogenase deficiency negative. [26678/15]
Simon Coveney (Cork South Central, Fine Gael)
Link to this: Individually | In context | Oireachtas source
As part of the screening process prior to deployment on a mission to a malarious area, an individual’s G6PD status is checked. As a matter of policy, those found to be deficient in G6PD are deemed unsuitable for deployment to a malarious area. While G6PD deficiency is not a contraindication to the use of Lariam (Mefloquine), if the individual is not found suitable for overseas service in a malarious area, he/she will not be required to use Lariam (Mefloquine) or Primaquine.
Clare Daly (Dublin North, United Left)
Link to this: Individually | In context | Oireachtas source
118. To ask the Minister for Defence the reason Primaquine was prescribed to soldiers by the Defence Forces, despite it being unlicensed and unregulated by the Health Products Regulatory Authority. [26679/15]
Simon Coveney (Cork South Central, Fine Gael)
Link to this: Individually | In context | Oireachtas source
Unfortunately it has not proved possible to compile the full information in response to this question in the time available. I will write to the Deputy when the information is to hand.
No comments